
NA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Description
NA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
North America Colorectal Cancer Diagnostics, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Market Definition:
Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer, short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.
Sometimes abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests can find polyps so they can be removed before becoming cancer. Screening also helps find colorectal cancer early, when treatment works best.
Market Segmentation:
North America colorectal cancer diagnostics market is categorized into six notable segments such as product type, test type, stages, cancer type, age group, and end user.
• On the basis of product type, the North America colorectal cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the North America colorectal cancer diagnostics market is segmented into stool examination, imaging tests, biopsy, blood tests, tumor markers, and others
• On the basis of stages, the North America colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of cancer type, the North America colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others
• On the basis of age group, the North America colorectal cancer diagnostics market is segmented into pediatric, adults, and geriatric
• On the basis of end user, the North America colorectal cancer diagnostics market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others
Market Players
Some of the major players operating in the North America colorectal cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Quest Diagnostics Incorporated
• CANON MEDICAL SYSTEMS CORPORATION.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• FUJIFILM Corporation
• Agilent Technologies, Inc.
• BD
• Siemens Healthcare GmbH
• Neusoft Corporation
• BioFire Diagnostics
• Myriad Genetics Inc.
• QIAGEN
• Hologic, Inc.
• Time Medical Holding.
• FONAR Corp.
• PlexBio
• MinFound Medical Systems Co., Ltd
• FONAR, Corp.
North America Colorectal Cancer Diagnostics, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Market Definition:
Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer, short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.
Sometimes abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests can find polyps so they can be removed before becoming cancer. Screening also helps find colorectal cancer early, when treatment works best.
Market Segmentation:
North America colorectal cancer diagnostics market is categorized into six notable segments such as product type, test type, stages, cancer type, age group, and end user.
• On the basis of product type, the North America colorectal cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the North America colorectal cancer diagnostics market is segmented into stool examination, imaging tests, biopsy, blood tests, tumor markers, and others
• On the basis of stages, the North America colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of cancer type, the North America colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others
• On the basis of age group, the North America colorectal cancer diagnostics market is segmented into pediatric, adults, and geriatric
• On the basis of end user, the North America colorectal cancer diagnostics market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others
Market Players
Some of the major players operating in the North America colorectal cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Quest Diagnostics Incorporated
• CANON MEDICAL SYSTEMS CORPORATION.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• FUJIFILM Corporation
• Agilent Technologies, Inc.
• BD
• Siemens Healthcare GmbH
• Neusoft Corporation
• BioFire Diagnostics
• Myriad Genetics Inc.
• QIAGEN
• Hologic, Inc.
• Time Medical Holding.
• FONAR Corp.
• PlexBio
• MinFound Medical Systems Co., Ltd
• FONAR, Corp.
Table of Contents
208 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The North America Colorectal Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 5 Industry Insights:
- 6 North America Colorectal Cancer Diagnostics Market, Regulations
- 6.1 Regulatory Scenario In The U.S
- 6.2 Regulatory Scenario In Australia
- 6.3 Regulatory Scenario In Japan
- 6.4 Regulatory Scenario In China
- 7 Market Overview
- 7.1 Drivers
- 7.1.1 Growing Prevalence Of Colorectal Cancer
- 7.1.2 Rise In The Number Of Patients Suffering From Diverticulitis And Ulcerative Colitis.
- 7.1.3 Rising Preference For Preventive Health Check-ups
- 7.2 Restraints
- 7.2.1 Stringent Regulatory Policies
- 7.2.2 High Cost For The Colorectal Cancer Treatments.
- 7.3 Opportunities
- 7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 7.3.2 Government Initiatives Toward Cancer Diagnostics
- 7.3.3 Strategic Initiatives By Market Players
- 7.4 Challenges
- 7.4.1 Increased Cost, Safety, And Convenience Issues
- 7.4.2 Lack Of Skilled And Certified Professionals
- 8 North America Colorectal Cancer Diagnostics Market, By Product Type
- 8.1 Overview
- 8.2 Instruments
- 8.2.1 Pathology-based Instruments
- 8.2.1.1 Pcr Instruments
- 8.2.1.2 Slide Staining Systems
- 8.2.1.3 Tissue Processing Systems
- 8.2.1.4 Cell Processors
- 8.2.1.5 Other Pathology-based Instruments
- 8.2.2 Imaging Instruments
- 8.2.2.1 Ultrasound Systems
- 8.2.2.2 Ct Systems
- 8.2.2.3 Mri Systems
- 8.2.2.4 Others
- 8.2.3 Biopsy Instruments
- 8.2.4 Others
- 8.3 Consumables & Accessories
- 8.3.1 Kits
- 8.3.1.1 Pcr Kits
- 8.3.1.2 Dna Polymerase Kits
- 8.3.1.3 Nucleic Acid Isolation Kits
- 8.3.1.4 Others
- 8.3.2 Reagents
- 8.3.2.1 Assays
- 8.3.2.2 Buffers
- 8.3.2.3 Primers
- 8.3.2.4 Others
- 8.3.3 Other Consumables
- 9 North America Colorectal Cancer Diagnostics Market, By Test Type
- 9.1 Overview
- 9.2 Stool Examination
- 9.3 Blood Test
- 9.3.1 Complete Blood Count (Cbc)
- 9.3.2 Tumor Marker Test
- 9.3.3 Liver Enzyme Blood Test
- 9.4 Imaging Test
- 9.4.1 Computed Tomography (Ct) Scan
- 9.4.2 Mri
- 9.4.3 Ultrasound
- 9.4.4 Position Emission Tomography (Pet)
- 9.4.5 Others
- 9.5 Tumor Markers
- 9.5.1 Carcinoembryonic Antigen (Cea)
- 9.5.2 Ca19-9 Biomarker Test
- 9.5.3 Ca 50 Marker Test
- 9.5.4 Others
- 9.6 Biopsy
- 9.7 Others
- 10 North America Colorectal Cancer Diagnostics Market, By Cancer Stages
- 10.1 Overview
- 10.2 Stage Iii
- 10.3 Stage Iv
- 10.4 Stage Ii
- 10.5 Stage I
- 10.6 Stage 0
- 11 North America Colorectal Cancer Diagnostics Market, By Age Group
- 11.1 Overview
- 11.2 Geriatric
- 11.3 Adults
- 11.4 Pediatric
- 12 North America Colorectal Cancer Diagnostics Market, By Cancer Type
- 12.1 Overview
- 12.2 Adenocarcinoma
- 12.3 Colorectal Lymphoma
- 12.4 Gastrointestinal Stromal Tumors
- 12.5 Carcinoid Tumors
- 12.6 Others
- 13 North America Colorectal Cancer Diagnostics Market, By End User
- 13.1 Overview
- 13.2 Hospitals
- 13.3 Diagnostic Centers
- 13.4 Cancer Research Centers
- 13.5 Ambulatory Surgical Centers
- 13.6 Academic Institutes
- 13.7 Others
- 14 North America Colorectal Cancer Diagnostics Market, By Region
- 14.1 North America
- 14.1.1 U.S.
- 14.1.2 Canada
- 14.1.3 Mexico
- 15 North America Colorectal Cancer Diagnostics Market, Company Landscape
- 15.1 Company Share Analysis: North America
- 16 Swot Analysis
- 17 Company Profile
- 17.1 F. Hoffmann- La Roche Ltd
- 17.1.1 Company Snapshot
- 17.1.2 Revenue Analysis
- 17.1.3 Company Share Analysis
- 17.1.4 Product Portfolio
- 17.1.5 Recent Development
- 17.2 Koninklijke Philips N.V.
- 17.2.1 Company Snapshot
- 17.2.2 Revenue Analysis
- 17.2.3 Company Share Analysis
- 17.2.4 Product Portfolio
- 17.2.5 Recent Development
- 17.3 Thermo Fisher Scientific Inc.
- 17.3.1 Company Snapshot
- 17.3.2 Revenue Analysis
- 17.3.3 Company Share Analysis
- 17.3.4 Product Portfolio
- 17.3.5 Recent Development
- 17.4 Illumina, Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Revenue Analysis
- 17.4.3 Company Share Analysis
- 17.4.4 Product Portfolio
- 17.4.5 Recent Development
- 17.5 Quest Diagnostics Incorporated
- 17.5.1 Company Snapshot
- 17.5.2 Revenue Analysis
- 17.5.3 Company Share Analysis
- 17.5.4 Product Portfolio
- 17.5.5 Recent Development
- 17.6 Abbott
- 17.6.1 Company Snapshot
- 17.6.2 Revenue Analysis
- 17.6.3 Product Portfolio
- 17.6.4 Recent Development
- 17.7 Agilent Technologies, Inc.
- 17.7.1 Company Snapshot
- 17.7.2 Revenue Analysis
- 17.7.3 Product Portfolio
- 17.7.4 Recent Development
- 17.8 Bd
- 17.8.1 Company Snapshot
- 17.8.2 Revenue Analysis
- 17.8.3 Product Portfolio
- 17.8.4 Recent Development
- 17.9 Beijing O&D Biotech Co., Ltd.
- 17.9.1 Company Snapshot
- 17.9.2 Product Portfolio
- 17.9.3 Recent Development
- 17.10 Biofire Diagnostics
- 17.10.1 Company Snapshot
- 17.10.2 Revenue Analysis
- 17.10.3 Product Portfolio
- 17.10.4 Recent Development
- 17.11 Bio-rad Laboratories, Inc.
- 17.11.1 Company Snapshot
- 17.11.2 Revenue Analysis
- 17.11.3 Product Portfolio
- 17.11.4 Recent Development
- 17.12 Canon Medical Systems Corporation.
- 17.12.1 Company Snapshot
- 17.12.2 Revenue Analysis
- 17.12.3 Product Portfolio
- 17.12.4 Recent Development
- 17.13 Fonar Corp.
- 17.13.1 Company Snapshot
- 17.13.2 Revenue Analysis
- 17.13.3 Product Portfolio
- 17.13.4 Recent Development
- 17.14 Fujifilm Corporation
- 17.14.1 Company Snapshot
- 17.14.2 Revenue Analysis
- 17.14.3 Product Portfolio
- 17.14.4 Recent Development
- 17.15 Ge Healthcare.
- 17.15.1 Company Snapshot
- 17.15.2 Revenue Analysis
- 17.15.3 Product Portfolio
- 17.15.4 Recent Development
- 17.16 Hologic, Inc.
- 17.16.1 Company Snapshot
- 17.16.2 Revenue Analysis
- 17.16.3 Product Portfolio
- 17.16.4 Recent Development
- 17.17 Medonica Co. Ltd
- 17.17.1 Company Snapshot
- 17.17.2 Product Portfolio
- 17.17.3 Recent Development
- 17.18 Merck Kgaa
- 17.18.1 Company Snapshot
- 17.18.2 Revenue Analysis
- 17.18.3 Product Portfolio
- 17.18.4 Recent Development
- 17.19 Minfound Medical Systems Co., Ltd
- 17.19.1 Company Snapshot
- 17.19.2 Product Portfolio
- 17.19.3 Recent Development
- 17.20 Myriad Genetics, Inc.
- 17.20.1 Company Snapshot
- 17.20.2 Revenue Analysis
- 17.20.3 Product Portfolio
- 17.20.4 Recent Development
- 17.21 Neusoft Corporation
- 17.21.1 Company Snapshot
- 17.21.2 Revenue Analysis
- 17.21.3 Product Portfolio
- 17.21.4 Recent Development
- 17.22 Plexbio
- 17.22.1 Company Snapshot
- 17.22.2 Product Portfolio
- 17.22.3 Recent Development 198
- List Of Tables
- Table 1 North America Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 2 North America Instruments In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 3 North America Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 North America Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 5 North America Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 North America Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 7 North America Consumables And Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 8 North America Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 9 North America Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 10 North America Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 11 North America Stool Examination In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 12 North America Blood Test In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 13 North America Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 14 North America Imaging Test In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 15 North America Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 16 North America Tumor Markers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 17 North America Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 18 North America Biopsy In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 North America Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 20 North America Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 21 North America Stage Iii In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 North America Stage Iv In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 North America Stage Ii In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 24 North America Stage I In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 North America Stage 0 In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 North America Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 27 North America Geriatric In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 North America Adults In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 29 North America Pediatric In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 North America Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 31 North America Adenocarcinoma In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 North America Colorectal Lymphoma In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 33 North America Gastrointestinal Stromal Tumors In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 34 North America Carcinoid Tumors In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 35 North America Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 North America Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 37 North America Hospitals In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 38 North America Diagnostic Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 North America Cancer Research Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 North America Ambulatory Surgical Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 41 North America Academic Institutes In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 North America Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 43 North America Colorectal Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 44 North America Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 45 North America Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 46 North America Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 47 North America Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 48 North America Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 49 North America Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 50 North America Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 51 North America Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 52 North America Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 53 North America Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 54 North America Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 55 North America Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 56 North America Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 57 North America Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 58 North America Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 59 U.S. Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 60 U.S. Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 61 U.S. Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 62 U.S. Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 63 U.S. Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 64 U.S. Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 65 U.S. Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 66 U.S. Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 67 U.S. Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 68 U.S. Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 69 U.S. Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 70 U.S. Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 71 U.S. Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 72 U.S. Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 73 U.S. Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 74 Canada Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 75 Canada Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 76 Canada Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 77 Canada Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 78 Canada Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 79 Canada Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 80 Canada Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 81 Canada Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 82 Canada Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 83 Canada Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 84 Canada Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 85 Canada Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 86 Canada Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 87 Canada Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 88 Canada Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 89 Mexico Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 90 Mexico Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 91 Mexico Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 92 Mexico Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 93 Mexico Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 94 Mexico Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 95 Mexico Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 96 Mexico Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 97 Mexico Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 98 Mexico Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 99 Mexico Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 100 Mexico Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 101 Mexico Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 102 Mexico Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 103 Mexico Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million) \
- List Of Figures
- Figure 1 North America Colorectal Cancer Diagnostics Market: Segmentation
- Figure 2 North America Colorectal Cancer Diagnostics Market: Data Triangulation
- Figure 3 North America Colorectal Cancer Diagnostics Market: Droc Analysis
- Figure 4 North America Colorectal Cancer Diagnostics Market: North America Vs Regional Market Analysis
- Figure 5 North America Colorectal Cancer Diagnostics Market: Company Research Analysis
- Figure 6 North America Colorectal Cancer Diagnostics Market: Interview Demographics
- Figure 7 North America Colorectal Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 8 North America Colorectal Cancer Diagnostics Market: Market End User Coverage Grid
- Figure 9 North America Colorectal Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 North America Colorectal Cancer Diagnostics Market: Segmentation
- Figure 11 The Increase In The Awareness About Colorectal Cancer Is Expected To Drive The North America Colorectal Cancer Diagnostics Market Growth In The Forecast Period
- Figure 12 The Instruments Segment Is Expected To Account For The Largest Share Of The North America Colorectal Cancer Diagnostics Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Colorectal Cancer Diagnostics Market
- Figure 14 North America Colorectal Cancer Diagnostics Market: By Product Type, 2022
- Figure 15 North America Colorectal Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 16 North America Colorectal Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 17 North America Colorectal Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 18 North America Colorectal Cancer Diagnostics Market: By Test Type, 2022
- Figure 19 North America Colorectal Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
- Figure 20 North America Colorectal Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
- Figure 21 North America Colorectal Cancer Diagnostics Market: By Test Type, Lifeline Curve
- Figure 22 North America Colorectal Cancer Diagnostics Market: By Cancer Stages, 2022
- Figure 23 North America Colorectal Cancer Diagnostics Market: By Cancer Stages, 2023-2030 (Usd Million)
- Figure 24 North America Colorectal Cancer Diagnostics Market: By Cancer Stages, Cagr (2023-2030)
- Figure 25 North America Colorectal Cancer Diagnostics Market: By Cancer Stages, Lifeline Curve
- Figure 26 North America Colorectal Cancer Diagnostics Market: By Age Group, 2022
- Figure 27 North America Colorectal Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 28 North America Colorectal Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 29 North America Colorectal Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 30 North America Colorectal Cancer Diagnostics Market: By Cancer Type, 2022
- Figure 31 North America Colorectal Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
- Figure 32 North America Colorectal Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
- Figure 33 North America Colorectal Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 34 North America Colorectal Cancer Diagnostics Market: By End User, 2022
- Figure 35 North America Colorectal Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 36 North America Colorectal Cancer Diagnostics Market: By End User, Cagr (2023-2030)
- Figure 37 North America Colorectal Cancer Diagnostics Market: By End User, Lifeline Curve
- Figure 38 North America Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 39 North America Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 40 North America Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 41 North America Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 42 North America Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 43 North America Colorectal Cancer Diagnostics Market: Company Share 2022 (%) 131
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.